baber/WOPTO huggingface dataset:
Patent FI-971559-A0 (FI)
Inventor: MAARSCHALKERWEERD JAN M
IPC: C02F1/36
Filed: 1997-04-14
Abstract: A fluid treatment device comprising a housing for receiving a flow of fluid, the housing comprising a fluid inlet, a fluid outlet, a fluid treatment zone disposed between the fluid inlet and the fluid outlet, and at least one radiation source module disposed in the fluid treatment zone, the at least one radiation source module comprising a radiation source sealably connected to a leg, the leg sealably mounted to the housing, the radiation source being disposed substantially parallel to the flow of fluid. A method of treating a fluid in a housing comprising a fluid inlet, a fluid outlet, a fluid treatment zone disposed between the fluid inlet and the fluid outlet, the fluid treatment zone having at least one radiation source disposed therein is also described. The method comprises the steps of: (i) providing a flow of the fluid to the fluid inlet; (ii) feeding the flow of fluid from the fluid inlet to the fluid treatment zone in a manner substantially parallel to the at least one radiation source; (iii) irradiating the flow of fluid in the fluid treatment zone; and (iv) feeding the flow of fluid to the fluid outlet. During the method, the flow of fluid through the fluid inlet, the fluid outlet and the fluid treatment zone is substantially collinear. The fluid treatment device and method are ideally suited (but not limited) to inactivate microorganisms present in water.
Patent FI-971937-A0 (FI)
Inventor: ZIMA GEORGE CHESTER
IPC: C08G69/46
Filed: 1997-05-06
Abstract: This invention relates to a process for recycling waste material selected from amino-carboxylic acid oligomers or polymers and amido-carboxylic acid oligomers or polymers into amido-carboxylic acids. A mixture containing water, an oligomeric or polymeric waste material, and a carboxylic acid is heated. The mixture is cooled to obtain a two phase system containing an aqueous phase and an organic phase which are separated. Carboxylic acids, unreacted starting materials, and the monomeric amido-carboxylic acid product are distilled from the organic phase. The remaining solid residue composed of high boiling oligomeric amino-carboxylic acids is recycled into Step (A).
Patent FI-973684-A0 (FI)
Inventor: AULANKO ESKO
IPC: H02K15/04
Filed: 1997-09-15
Abstract: The invention relates to a procedure for preparing the windings for an electric motor. The magnetic core (20) of the stator and/or rotor of the motor is provided with slots (24,25) in which winding coils (2; 5,7;15,17) can be fitted. According to the invention, the winding coils (2) are wound from winding wire and shaped substantially into their final form, the cross-section of the coil sides (15,17) corresponding to the space reserved in the slot (24,25) for the coil. The winding coils (15,17) are fitted in place in the slots (24,25) provided in the magnetic core.
Patent IL-70765-A0 (IL)
Title: Methods and structures employing non-radioactive chemicallylabeled polynucleotides
IPC: C07H21/04
Filed: 1984-01-23
Abstract: Non-radioactive chemically-labeled polynucleotide probes, such as non-radioactive chemically-labeled, single-stranded DNA probes, are hybridized to fixed, denatured, single-stranded genetic material having a make-up complementary to said probes for determining the identification and/or presence of said genetic material. The non-radioactive chemical label on said probe is employed to elicit a response therefrom so as to determine the identity and/or presence of said genetic material. It is preferred that the non-radioactive chemical label attached to the probe have an enzyme attached thereto after hybridization, and that the presence of the enzyme attached to the chemically-labeled probe be elicited by spectrophotometric assay techniques.
Patent IL-75732-A0 (IL)
Title: Synthesis of hgrf(somatocrinin)in liquid phase and intermediate peptides
IPC: A61K38/22
Filed: 1985-07-05
Abstract: A process for the synthesis, in liquid phase and by fragments, of hGRF 1-44 and hGRF 1-40. This process consists in coupling, one after the other and in the order of the sequence of the GRF, (1) on the one hand, the following fragments: -H-Ala-Arg-Ala-Arg-Leu-NH2 called Fragment A hGRF (40-44) or -   alaninamide (40) -H-Gln-Glu-Arg-Gly-OH called Fragment B'1 hGRF (36-39) -H-Glu-Ser-Asn-OH called Fragment B'2 hGRF (33-35) -H-Ser-Arg-Gln-Gln-Gly-OH called Fragment C hGRF (28-32) -H-Leu-Gln-Asp-Ile-Met-OH called Fragment D' hGRF (23-27) -H-Arg-Lys-Leu-OH called Fragment E'1 hGRF (20-22) -  to obtain the peptide K1 [(hGRF (20-44)] on the corresponding peptide having the sequence (20-40) and (2) on the other hand, the following fragments: -H-Gln-Leu-Ser-Ala called Fragment F1 hGRF (16-19) -H-Tyr-Arg-Lys-Val-Leu-Gly OH called Fragment G1 hGRF (10-15) -H-Ile-Phe-Thr-Asn-Ser-OH called Fragment H1 hGRF (5-9) -  to obtain the peptide J [hGRF (5-19)] and thereafter to couple together the peptides J and K1 in order to form the peptide having the sequence hGRF (5-44) or hGRF (5-40) and finally to couple the resulting peptide with the peptide H-Tyr-Ala-Asp-Ala-OH, called fragment I hGRF (1-4).
Patent IL-82717-A0 (IL)
Title: Peptides that inhibit von willebrand factor binding
IPC: A61K31/00
Filed: 1987-05-29
Abstract: Peptides which inhibit the binding of von Willebrand factor to platelets, heparin and collagen. The method of preventing thrombosis, by administering one or more of these peptides, is also disclosed.
Patent IL-96996-A0 (IL)
Title: Preparation of ergoline derivatives
IPC: C07D457/00
Filed: 1991-01-22
Abstract: PCT No. PCT/EP91/00104 Sec. 371 Date Sep. 25, 1991 Sec. 102(e) Date Sep. 25, 1991 PCT Filed Jan. 21, 1991 PCT Pub. No. WO91/11447 PCT Pub. Date Aug. 8, 1991.Ergoline derivatives of the formula I: <IMAGE> I  wherein R represents hydrogen or C1-C4 alkyl; R1 represents hydrogen, chlorine, bromine or methyl; either R2 and R3 both represent hydrogen or together represent a chemical bond; R4 represents a C1-C4 hydrocarbon group; each of R5, R6, R8 and R9 independently represents hydrogen or C1-C4 alkyl; R7 represents hydrogen, C1-C4 alkyl, phenyl or C3-C7 cycloalkyl and n is 0, 1 or 2; are prepared by reaction between compounds of the formulae II and III:   <IMAGE> II  <IMAGE> III   and subsequent cyclization of the resultant compounds. The compounds of the formula I are known useful anxiolytic, antipsychotic and anti-parkinson agents.
Patent FI-20012535-A0 (FI)
Inventor: KOLINUMMI PASI
IPC: G06F1/32
Filed: 2001-12-20
Abstract: The invention relates to a method and device for implementing dynamic power control in an electronic system implemented on an integrated circuit, which electronic system comprises at least one or several hardware units (201, 202, 203), a hardware based power control logic (204) substantially implemented with logic circuits, as well as a programmable power control mode register (208) containing information about powered-down modes defined for said one or more hardware units. According to the invention, to transfer a single hardware unit (201, 202, 203) from the powered-down mode to the operational mode, said hardware unit transmits to the power control logic (204) a first level sensitive status signal (201a, 202a, 203a) for transferring said hardware unit from the powered-down mode to the wake up mode, and further a second level sensitive status signal (201b, 202b, 203b) for transferring said hardware unit from the wake up mode to the actual operating mode. Said wake up mode is characterized in that the transfer of said hardware unit (201, 202, 203) from the wake up mode to the actual operational mode is now effected with a known, preferably short delay, and that the power consumption in the wake up mode is lower than in the actual operational mode. The invention makes it possible to achieve aggressive power savings. <IMAGE>
Patent FI-20070520-A0 (FI)
Inventor: HALLIVUORI MATTI
IPC: G06F/
Filed: 2007-07-02
Abstract: Each received piece of configuration data is added at a next currently free location in a volatile buffer. The contents of the volatile buffer are compressed after adding each received piece of configuration data. The compression result is stored in a non-volatile flash memory. If the compression result was shorter than a limit, it is allowed to be overwritten in the flash memory by a next compression result. If the compression result was longer than said limit, it is stored in the flash memory and the next compression result is directed to a different location in the flash memory.
Patent IL-110055-A0 (IL)
Title: Positive inotropic and lusitropic pyrroloquinolinone derivatives, their preparation and pharmaceutical compositions containing them
IPC: C07D207/448
Filed: 1994-06-20
Abstract: PCT No. PCT/EP94/01960 Sec. 371 Date Nov. 29, 1995 Sec. 102(e) Date Nov. 29, 1995 PCT Filed Jun. 15, 1994 PCT Pub. No. WO95/00512 PCT Pub. Date Jan. 5, 1995The present invention relates to novel positive inotropic and lusitropic compounds of formula d addition salts thereof and the stereochemically isomeric forms thereof wherein L is a radical of formula -O-Alk-(NH)p-C(=O)-R1, pharmaceutical compositions thereof, methods of preparing said compounds and intermediates in the preparation thereof.
Patent IL-114177-A0 (IL)
Title: Covalently coupled benzoylecgonine ecgonine and ecgonidine derivatives and pharmaceutical compositions containing the same
IPC: A61P17/00
Filed: 1995-06-15
Abstract: The present invention relates to a novel class of covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives that are useful for alleviating the symptoms of immunoregulatory disorders, neuromuscular disorders, joint disorders, connective tissue disorders, circulatory disorders and pain. Accordingly, this invention also relates to pharmaceutical compositions and methods for their use.
Patent IL-124676-A0 (IL)
Title: Improved concentrated injection and infusion solutions for intravenous use
IPC: A61P7/02
Filed: 1997-01-27
Abstract: Additives to concentrated injection and infusion solutions that avoid or mitigate acute or delayed hypersensitivity reactions as well as injection and infusion solutions that contain these additives are described.
Patent IL-126836-A0 (IL)
Title: Therapeutic treatment for vegf related ocular diseases
IPC: C07D487/22
Filed: 1997-05-01
Abstract: Method of treating a ocular vascular disorders comprises administration of an inhibitor of the ~b-isozyme of protein kinase C. Protein kinase C is (S)-3,4-(N,N'-1,1'-((2"-ethoxy) -3"'(O)-4"'-(N,N-dimethylamino) -butane)-bis-(3,3'-indolyl)) -1(H)-pyrrole-2,5-dione.
Patent IL-140716-A0 (IL)
Title: Use of inhibitors of protein kinase c epsilon to treat pain
Inventor: MESSING ROBERT O
IPC: A61K38/45
Filed: 1999-07-06
Abstract: The role of  epsilon  isozyme of protein kinase C ("PKC epsilon ") in pain perception, particularly hyperalgesia, methods of lessening pain through administration of inhibitors of PKC epsilon , methods of identifying compounds that modulate pain, uses of inhibitors of PKC epsilon  in the preparation of a medicament for the treatment of pain, and pharmaceutical compositions comprising an inhibitor of PKC epsilon  and PKC epsilon -independent analgesic agent are disclosed.
Patent IL-141920-A0 (IL)
Title: Process for the preparation of alkyl mercapto methyl ergoline derivatives
IPC: A61P25/16
Filed: 1999-12-31
Abstract: Process for the preparation of compounds active in the treatment of Parkinson's disease, and such compounds, having general formula (VI) wherein R4 may be, independently, a linear, branched or cyclic, saturated or unsaturated C1-8 alkyl radical, such as, for example, the radicals methyl, ethyl, propyl, butyl, isobutyl, tert-butyl, pentyl, cyclopentyl, hexyl, cyclohexyl and octyl. The process utilizes as starting materials the compound of formula (I) wherein R1 represents a linear, branched or cyclic, saturated or unsaturated C1-8 alkyl residue.
Patent IL-142542-A0 (IL)
Title: Tablet dispenser
IPC: A61J1/03
Filed: 1999-11-09
Abstract: A tablet dispenser for consecutive administering of tablets, the dispenser comprising a circular container (21) in which tablets are stored in a number of compartments (24) along the perimeter of the container, and a circular lid (22) concentric with the container, which lid (24) covers the compartments (24) and has a dispensing opening allowing access to one compartment at the time when the lid is rotated relative to the container. A cylindrical surface on the container part forms a pawl wheel provided with teeth (32) each having a ramp shaped and a steep edge and the lid (22) is provided with elongated, flexible pawls (30) which are at one end fixed to the lid (22) and follows a chord of the circular device to engage the teeth (32) of the pawl wheel by its other free end.
Patent IL-143764-A0 (IL)
Title: Integrated transmitter and receiver components for a dual-band transceiver
IPC: H04B1/40
Filed: 1999-11-17
Abstract: A transceiver of a dual-band radio is provided that selectively transmits and receives on either of a first frequency and a second frequency wherein the transceiver includes an integrated circuit having a power amplifier configured to amplify signals for transmission on a first frequency, and a low-noise amplifier configured to amplify signals received on the second frequency. The transceiver may further include a second integrated circuit having a power amplifier configured to amplify signals for transmission on a second frequency, and a low-noise amplifier configured to amplify signals received on the first frequency.
Patent IL-148143-A0 (IL)
Title: An improved ultraviolet sterilization apparatus
IPC: A61L9/20
Filed: 2000-11-28
Abstract: An ultraviolet sterilization apparatus comprising a housing and a replaceable lamp cartridge package. The lamp cartridge package is a disposable component comprising at least one ultraviolet lamp and an envelope for housing the at least one ultraviolet lamp, the envelope comprising a jacket with a reflective inner surface, an envelop air inlet opening and an envelop air outlet opening, and at least one air-transmitting, ultraviolet-stopping device adjacent at least one of the two envelope openings. The housing has an opening for the inlet of an air flow to be sterilized and an opening for the outlet of a sterilized air flow, said air flow being generated by a fan inside the housing.
Patent IL-149425-A0 (IL)
Title: Method for producing a moulded body containing starch
IPC: A61K9/48
Filed: 2000-11-16
Abstract: In the preparation of a starch-containing shaped article by (a) converting a mixture of starch, water and organic plasticizer into a homogeneous thermoplastic melt, by melting and kneading, (b) optionally preparing a storable intermediate product by cooling, then melting this product, (c) preparing at least one strand of the obtained material, (d) shaping into the article and (e) optionally drying, steps (a)-(c) are carried out such that the mass forming the strand in step (d) has a Staudinger index value of at least 40. Preparation of a starch-containing shaped article involves: (a) converting a mixture of starch (preferably at 45-80 wt. %), water and organic plasticizer(s) (I) into a homogeneous thermoplastic melt, by melting and kneading in a first apparatus, (b) optionally preparing a storable intermediate product (especially a granulate) by cooling, then melting this product in a second apparatus; (c) preparing at least one strand of material (preferably an extruded film) at the outlet of the first or second apparatus; (d) shaping the strand into an article in a continuous or intermittent forming process; and (e) optionally drying. The novel feature is that steps (a)-(c) are carried out such that the mass forming the strand in step (d) has a Staudinger index value of at least 40 (especially at least 60). Independent claims are included for: (i) a homogenized mass containing (preferably at least 45 wt. % of) amorphous starch having an amylopectin content of at least 50 wt. % (based on anhydrous starch) and at least 12 wt. % (based on anhydrous starch) of (I), having a Staudinger index value as above; (ii) a shaped article formed by the above process and/or from a mass as in (i); and (iii) apparatus for preparing a soft capsule from a mass as in (i) by the above process, where at least two film sheets are formed into a unitary capsule shell and provided with the capsule contents at a forming and filling station, the sheets being formed by an extruder located at this station and converted directly into the capsule.
Patent IL-152515-A0 (IL)
Title: A parachute slider with nozzles
IPC: B64D17/34
Filed: 2002-10-28
Abstract: The pilot chute (1) for a parachute or inflatable supple wing comprises a flat or domed panel with its underside (2) bordered by a hem (4) with fixing points (3) spaced sufficiently far apart to allow the hem to open under the action of an air flow applied to the underside, leading to a progressive opening of the canopy at high altitude. The fixing points are in the form of eyelets through which the parachute lines pass.
Patent IL-154223-A0 (IL)
Title: Door shutter mechanism
IPC: E06B9/302
Filed: 2003-01-30
Abstract: A stacking mechanism for shutter members of a shutter mechanism, comprising: a rotatable screw with external thread of length L and pitch P 1 ; a plurality of N traveling nuts mounted on the screw, having internal thread of pitch P 1 and external thread of pitch P 2 ,P 1 >P 2 ; an arrester preventing rotation of the nuts within a length L 1 of the screw, while allowing sliding; and a threaded member of pitch P 2 adapted to engage the external thread of the nuts within a length L 2 of the screw. In a first position of the mechanism, the nuts are arranged over the length L 1 . Upon rotation of the screw, the nuts slide along the screw at rate P 1 per 1 turn, transit from L 1 to L 2 , and then slide within the length L 2 at a rate P 2 per 1 turn, thereby achieving reversibly a second position of the mechanism where they are arranged over the length L 2 ,L 2 <L 1.
Patent IL-154605-A0 (IL)
Title: Vaccine composition
IPC: A61P37/04
Filed: 2001-10-18
Abstract: The invention relates to a vaccine which comprises at least one antigen and a peptide comprising a sequence R1—XZXZNXZX—R2, whereby N is a whole number between 3 and 7, preferably 5, X is a positively charged natural and/or non-natural amino acid residue, Z is an amino acid residue selected from the group consisting of L, V, I, F and/or W, and R1 and R2 are selected independently one from the other from the group consisting of —H, —NH2, —COCH3, —COH, a peptide with up to 20 amino acid residues or a peptide reactive group or a peptide linker with or without a peptide; X—R2 may also be an amide, ester or thioester of the C-terminal amino acid residue, as well as the use of said peptide for enhancing a patient's adaptive immune response to an antigen.
Patent IL-162389-A0 (IL)
Title: System and methods for conveying and transporting levitated articles
IPC: B65G49/06
Filed: 2002-12-27
Abstract: A non-contact support platform for supporting without contact a stationary or traveling object by air-cushion induced forces, the platform comprising at least one of two substantially opposite support surfaces, each support surfaces comprising at least one of a plurality of basic cells each having at least one of a plurality of pressure outlets and at least one of a plurality of air-evacuation channels at least one of a plurality of outlets, and one of a plurality of air-evacuation channels, each of the pressure outlets fluidically connected through a pressure flow restrictor to a high-pressure reservoir, the pressure outlets providing pressurized air for generating pressure induced forces, maintaining an air-cushion between the object and the support surface, the pressure flow restrictor characteristically exhibiting fluidic return spring behavior; each of said at least one of a plurality of air-evacuation channels having an inlet and outlet, the inlet kept at an ambient pressure or lower, under vacuum condition, for locally discharging mass flow, thus obtaining uniform support and local nature response.
Patent IL-163690-A0 (IL)
Title: Ground cover for cultivation of plants
IPC: A01G13/02
Filed: 2002-02-25
Abstract: A ground cover for cultivation of plants includes a membrane strip having a side which in use is an upper side, and anchoring formations on the upper side of the membrane strip. The anchoring formations assist a plant in the vicinity of the ground cover to anchor itself to the ground cover.
Patent IL-164160-A0 (IL)
Title: Device for the injection moulding of moulded bodies made from plastic
IPC: H01L29/72
Filed: 2002-04-17
Abstract: A device for the injection moulding of moulded bodies made from plastic is disclosed, comprising an injection moulding unit ( 1 ) and a tool ( 2 ) dedicated thereto. At least two cavities ( 11, 12 ), corresponding to the dimensions of the moulded body for production are provided on the tool ( 2 ) and the tool comprises at least three pieces ( 4, 5, 6 ), which move relative to each other and which lie adjacent to each other on separating planes ( 9, 10 ). Each separating plane ( 9, 10 ) runs through at least one cavity ( 11, 12 ). At least one channel ( 13 ) for the introduction of molten plastic is provided in the tool ( 2 ), which terminates at one end in the cavities ( 11, 12 ) and at the other end thereof at an inlet ( 14 ) on the surface of the tool ( 2 ), which is connected to the injection moulding unit ( 1 ) in the working position. In order to increase the number of moulded bodies produced per unit time, a channel ( 13 ) is provided in the tool ( 2 ), reaching from the inlet ( 14 ) to a first separating plane ( 9 ) and further leading to the second separation plane ( 10 ).
Patent IL-177953-A0 (IL)
Title: Combination therapy including azd2171 and a taxane
IPC: A61K31/337
Filed: 2006-09-07
Abstract: The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises the administration of AZD2171 in combination with a taxane; to a pharmaceutical composition comprising AZD2171 and a taxane; to a combination product comprising AZD2171 and a taxane for use in a method of treatment of a human or animal body by therapy; to a kit comprising AZD2171 and a taxane; to the use of AZD2171 and a taxane in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation.
Patent IL-218336-A0 (IL)
Title: Polynucleotides encoding truncated glial derived neurotrophic factors and methods of using said polynucleotides
IPC: C07K14/475
Filed: 2012-02-27
Abstract: Disclosed are novel proteins, referred to as truncated glial cell line-derived neurotrophic factor (truncated GDNF) proteins, that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells. Also disclosed are processes for obtaining the truncated GDNF proteins by recombinant genetic engineering techniques.
Patent IL-220780-A0 (IL)
Title: System for electrically connecting batteries to electric vehicles
IPC: H01M50/249
Filed: 2012-07-05
Abstract: A method of exchanging a battery in an at least partially electric vehicle comprises removing a first battery from a cavity in an underside of an at least partially electric vehicle, inserting the second battery into the cavity in the underside of the at least partially electric vehicle, temporarily storing at least one of said first and second batteries in a standby location (1308) during said exchange process to thereby reduce a time duration required for said exchange process.